Cancer
OptimICE-pCR
Breast Cancer
De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
Contact Research Team:
[email protected]
Site principal investigator:
Whitney Hensing, MD
Learn more about this study:
NCT05812807